Spi-1005 Updates 2024. Seattle, washington — sound pharmaceuticals has announced that it has enrolled the first patient in its phase 3 clinical trial involving spi. 28 jul, 2022, 09:15 et.
Seattle — sound pharmaceuticals is pleased to announce that the fda’s division of neurology products has granted its request for fast track designation. (spi) is pleased to announce a cooperative grant award from the national center.
03 May, 2023, 11:00 Et.
Sound pharmaceuticals is pleased to announce that the fda's division of neurology products has granted its request for fast track designation (ftd) involving.
Seattle, Washington — Sound Pharmaceuticals, A Biopharmaceutical Company, Has Announced The Completion Of Enrollment In Its Phase 3.
Seattle — sound pharmaceuticals is pleased to announce that the fda’s division of neurology products has granted its request for fast track designation.
11 May, 2022, 09:10 Et.
Images References :
(Spi) Is Pleased To Announce A Cooperative Grant Award From The National Center.